HMPL-760 is a highly potent and selective reversible BTK inhibitor, targeting BTK and BTKC481S in B-cell malignanciesLinfang Wang,Junqing Liang, Zhihu Gao,Jia Hu, Weigang He,Xianwen Yang, Fangfang Mao,Wei Zhang, Ying Yu,Qihang Zhang,Na Yang,Chun Zhang,Jian Wang,Yu Cai,Xiong Li,Weiguo Qing,Guangxiu Dai,Yongxin Ren,Michael Shi,Weiguo SuCANCER RESEARCH(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要